Page last updated: 2024-08-25

1-hydroxy-2(1h)-pyridinone and Parkinson Disease

1-hydroxy-2(1h)-pyridinone has been researched along with Parkinson Disease in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Amarandei, CA; Bergin, JCJ; Brandel, J; Dejaegere, A; Hubscher-Bruder, V; Nelson, AK; Stote, RH; Tan, KK; Tétard, D; Voinarovska, V1

Other Studies

1 other study(ies) available for 1-hydroxy-2(1h)-pyridinone and Parkinson Disease

ArticleYear
1-Hydroxy-2(1
    Molecules (Basel, Switzerland), 2022, Apr-28, Volume: 27, Issue:9

    Topics: Benzophenones; Catechol O-Methyltransferase; Catechol O-Methyltransferase Inhibitors; Catechols; Chelating Agents; Enzyme Inhibitors; Ferric Compounds; Humans; Nitrophenols; Parkinson Disease; Pyridones

2022